Library
Increased impact of a contraceptive vaginal ring with ethinyl estradiol and nestorone on C-reactive protein.
1 November 2012. doid: 10.1016/j.steroids.2012.08.003
Rad M, Burggraaf J, Sitruk-Ware RL, de Kam ML, Cohen AF, Kluft C
View publicationOBJECTIVE & STUDY DESIGN: In a parallel design, 23 and 22 healthy pre-menopausal women were randomly administered a contraceptive vaginal ring (CVR) delivering 150/15 μg Nestorone®/ethinyl estradiol (EE) daily or an oral contraceptive (OC) containing levonorgestrel and EE (150/30 μg) for three cycles, to compare the effects on C-reactive protein and other markers of inflammation. ANCOVA was performed with baseline values as covariate.
Advancing the boundaries of clinical drug development
Wondering how we can help you? Reach out to us.
